Spruce Biosciences, Inc. Common Stock (SPRB)

• Market cap: $97M
• 1 day: 0.5%
• 5 days: -18.37%
• 1 month: -13.66%
• 3 months: 824.59%
• 6 months: 824.59%
• Year to date: 188.02%
• 1 year: 132.33%
• 5 years: -95.85%
• 10 years: -92.89%
• Sector: Healthcare
• Industry: Biotechnology

About: Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Employees: 20